BSERavelcare LimitedMinimalNeutral
Announced Wed, 23 Sept, 2026 · 15:12 IST

Ravelcare 8th AGM: All 4 resolutions passed with 100% approval

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹104.50
prior close
₹104.50
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-1.3% vs market
Personal Care peers, median of 14sector+1.1%-1.1% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 1.1 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0+1.3-1.3+1.1-1.1
Next day
-4.1-0.2-3.9+0.0-4.2
2d
-5.3+0.1-5.3+0.4-5.7
3d
-3.3-1.5-1.8-0.9-2.4
4d
—-0.5—-1.3—
5d
-2.4-0.8-1.6-1.1-1.2
1w
-3.5-2.0-1.5-3.3-0.3
15d
—-3.4—-1.2—
1m
-11.7-9.9-1.8-2.4-9.3
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Personal Care peers, median of 14Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ravelcare Limited held its 8th AGM on September 23, 2026 via video conferencing. All 4 resolutions were passed unanimously with 100% votes in favor (50,05,999 votes; 72.98% of 68,59,000 outstanding shares polled). These include: adoption of audited financial statements for FY ending March 31, 2026; re-appointment of Mrs. Anita Mahesh Varma as director retiring by rotation; and special resolutions to re-appoint Mr. Ayush Varma as Managing Director and Mr. Maheshkumar Varma as Whole-time Director. Total 379 shareholders on record date, with 4 promoter shareholders attending via VC.

Likely market impact

Routine procedural outcome with full shareholder backing of management and financial statements. No material impact on stock expected.